Cholestyramine
Analysis, Treatment, Product, MSDS, Effects,Process, Toxicity, Suppliers, Report
Primary
Information Services
Home.
Ordering Information.
Contact
|
- Cholestyramine (CSM)
is an FDA-approved medication used to lower elevated levels of
cholesterol.
- Cholestyramine is
a quaternary ammonium anion exchange resin with a strong affinity
for bile salts.
-
Cholestyramine is a co-polymer of styrene and divinylbenzine, its
molecular weight is about one million and it is irisoluble in water.
-
Cholestyramine or
colestyramine (Questran, Questran Light, Cholybar) is a bile acid
sequestrant, which binds bile in the
gastrointestinal tract to prevent its reabsorption.
-
Cholestyramine is a
strong ion exchange resin, which means that it can exchange its
chloride anions with anionic bile acids in the gastrointestinal
tract and bind them strongly in the resin matrix.
-
Cholestyramine
removes bile acids from the body by forming insoluble complexes with
bile acids in the intestine, which are
then excreted in the feces. When bile acids are excreted, plasma
cholesterol is converted to bile acid to normalize bile acid
levels. This conversion of cholesterol into bile acids lowers plasma
cholesterol concentrations.
-
Cholestyramine
removes certain chemicals from the body which leads to more
cholesterol being broken down. This lowers the level of cholesterol
in the blood. Lowering cholesterol can prevent heart and blood
vessel disease.
- Cholestyramine is
also used to treat severe itching caused by liver disease.
- Cholestyramine
can also be used to treat diarrhea.
- Cholestryamine is
also used to treat diarrhea-predominant IBS, cardiac glycoside
toxicity, diarrhea associated with excess fecal bile acids (such as
in patients with a resected bowel), and pseudomembraneous colitis.
- Cholestyramine is
used to treat the itching that occurs with certain types of liver
disease. Itching occurs because of retention of bile salts which are
made by the liver. Cholestyramine binds these bile salts in the
intestinal tract, thereby reducing them in the blood and relieving
the itching that elevated bile salts can cause.
- Cholestyramine
can affect how other medications work when taken at the same time.
Take other medications 1 hour before or 4 to 6 hoursafter taking
Cholestyramine.
- Cholestyramine
resin acts by releasing chloride and combining it with bile acids in
the intestine to form insoluble, nonabsorbable complexes that are
excreted in the feces along with unchanged resin. The excretion in
the feces prevents the bile acids from returning to the liver by
enterohepatic circulation.
- Lowering the bile
acid concentration in the hepatocytes causes an increased conversion
of cholesterol to bile acids, resulting in a replenished supply of
these compounds, which are essential components of the bile. This
causes a decrease in the intracellular cholesterol concentration,
which activates an increased uptake of LDL particles. The final
outcome is a decreased plasma cholesterol concentration.
- Cholestyramine
(Questran) works by chemically binding the bile acids produced by
the gall bladder.
- Cholestyramine
drug may interfere with the absorption and digestion of fats and fat
soluble vitamins such as A, D, E and K. It may be necessary to
supplement these vitamins as well as calcium and folic acid.
- Cholestyramine
has been
used safely for over forty years in millions of patients who have
taken the medication for extended periods of time.
- Cholestyramine is
one of the oldest and relatively safest cholesterol lowering
medications on the market today.
|
General
Information
-
Cholestyramine Information
-
Cholestyramine
Basic Info
-
Cholestyramine Information Card
-
Questran
Uses
-
Cholestyramine resin
-
Cholestyramine and its role in C. difficile
infections
-
Questran (cholestyramine)
powder
Fact Sheet
-
Cholestyramine (CSM) Facts
-
Cholestyramine side
effects Facts
-
Questran
Fact Sheet
Data Sheet
-
Cholestyramine
-
Questran
Lite
-
Cholestyramine
Resin from Texas
-
Cholestyramine Resin USP
-
Cholestyramine Resin from USA
-
Cholestyramine from Germany
Product
-
Duolite
-
Prevalite
-
Questran
-
Cholestyramine
-
Cholestyramine USP
-
Cholestyramine 5% Ointment
-
Cholestyramine Ointment
-
Cholestyramine Light
-
Cholestyramine Paste
Process
-
Calorimetric evaluation of hydration of cholestyramine
-
The use of histological techniques for the
demonstration of ion exchange resins
-
Production Cholestyramine via catalytic Green Copolymerization
method in the presence of supported Heteropolyacids
Report
-
Enhanced elimination of warfarin during
treatment with cholestyramine
-
Cholestyramine Good for Diarrhea
-
Hypoprothrombinemic
hemorrhage due to
cholestyramine therapy
-
Doxepin-Cholestyramine Interaction
-
Arteriohepatic Dysplasia:
A 16-Year Follow-up
During Treatment With
Cholestyramine
-
Cholestyramine for Diarrhea
-
Questran available as Questran Lite
-
Report -
Cholestyramine in uraemic pruritus
Effects
-
Effect of Cholestyramine on Bile Acid
Metabolism in Normal Man
-
Hypolipidemic Effect of Flavonoids and
Cholestyramine in Rats
-
Chronic diarrhoea in non collagenous
microscopic colitis - Therapeutic effect of cholestyramine
-
Evaluation of the Effects of Cholestyramine on
the Pharmacokinetics
-
Effect of cholestyramine on telepaque oral
cholecystography
-
Bile acids and vitamin A absorption in man:
the effects of two bile acid-binding agents, cholestyramine and
lignin
-
Effects of Cholestyramine on Receptor-mediated
Plasma Clearance and Tissue Uptake of Human Low Density Lipoproteins
in the Rabbit
-
Effects of Cholestyramine on Low Density
Lipoprotein Binding Sites onLiver Membrane
-
Effect of Cholestyramine on Fecal Excretion
-
Effects of cholestyramine on
HMG-CoA reductase activity and low density lipoprotein receptor
expression in gallstone patients
-
Effects of gluten free diet and cholestyramine
-
Effects of the Cholestyramine on the Induction
of Intestinal Tumors in Rats by Azoxymethane
-
Effects cholestyramine on bile lipid
composition in patients with hypercholesterolaemia
-
Effect of cholestyramine and Mevinolin on the
diurnal cycle of rat
-
Effect of psyllium and
cholestyramine in the hamster
-
Effect of Cholestyramine on the formation of
pigment gallstone in high carbohydrate diet-fed hamsters
-
Effects of Cholestyramine and Diet on Small Intestinal
Histomorphometry in Rats
|
Application
-
Ability
of cholestyramine resin to bind Escherichia coli enterotoxins
-
Prevention of Bile Reflux-Induced Acute
Gastric Ulceration in the Rat by Cholestyramine
-
Utilization of cholestyramine resin as a
preventive treatment for antibiotic induced enterotoxaemia in
the rabbit
-
Cholestyramine Therapy for Dyslipidemia in
Non-Insulin-dependent Diabetes Mellitus
-
Interruption of the Enterohepatic
Circulation of Digitoxin by Cholestyramine
-
Low-Dose Therapy with Fluvastatin and
Cholestyramine in Hyperlipidemic Patients
-
Pharmaceutical Applications
for Ion Exchange Resins
-
Ion Exchange resins: Pharmaceutical applications and recent
advancement
-
Clinical trials of cholestyramine
Patent
- Edible, baked
compositions containing cholestyramine
-
Psyllium
cholestyramine compositions with improved palatability
-
Palatable
cholestyramine granules, tablets and methods for preparation
thereof
- Edible,
non-baked low moisture cholestyramine composition
-
Palatable cholestyramine coacervate
compositions
- Direct
compression cholestyramine tablet and solvent-free coating
thereof
-
Cholestyramine compositions and method for treating biliary
gastritis
-
Cholestyramine compositions and method for
preparation thereof
-
Composition containing cholestyramine and method of producing
the same
-
Cholestyramine ointment to treat
persistent diaper rash in an infant
-
Treatment of phenprocoumon
intoxication with cholestyramine
Analysis
-
Analysis of the In Vitro Interaction Between
Vancomycin and Cholestyramine
-
Cholestyramine Powder in vitro Bioequivalence
-
Comparison of the In Vitro Activities of
Teicoplanin and
Vancomycin against Clostridium difficile and Their Interactions with
Cholestyramine
-
Efficacy and Safety of
Diclofenac-Cholestyramine in Osteoarthritis
-
Efficacy and Safety of Ursodeoxycholic Acid
Versus
Cholestyramine in Intrahepatic Cholestasis of Pregnancy
-
Intestinal obstruction association with
cholestyramine therapy
-
Mathematical model and dimensional analysis of
glycocholate binding to cholestyramine resin
-
Sodium Cholate Sorption on
N-Octadecylpectinamide in Comparison with Cholestyramine
Study
-
Absorption of Dietary Fats by the Rat in
Cholestyramine-induced Steatorrhea
-
Cholestyramine and a Fat-Free Diet Lower
Apolipoprotein A-IV mRNA in Jejunum of Rats
-
Catabolism of low density lipoproteins by
perfused rabbit livers: Cholestyramine promotes receptor-dependent
hepatic catabolism of low density lipoproteins
-
Cholestyramine resin ameliorates chronic
aminoncleoside nephrosis
-
Cholestyramine Reverses Hyperglycemia and
Enhances
Glucose
-
Cholestyramine on Serum Lipids in
Hypercholestrolaemic Rabbits
-
Influence of changes in lipid values induced
by cholestyramine and diet on progression of coronary artery disease
-
Cholestyramine inhibit the direct synthesis of
low density lipoprotein apolipo protein B in miniature pigs
Treatment
-
Mechanisms of Action of Cholestyramine in the
Treatment of Hypercholesterolemia
-
Acipimox in combination with low dose
cholestyramine for the
treatment of type II hyperlipidaemia
-
Influence of
Maternal Cholestyramine Treatment on
Cholesterol and Bile Acid Metabolism in Adult
Offspring
Suppliers
-
Cholestyramine suppliers
- Suppliers
for Cholestyramine
-
Cholestyramine suppliers
-
Suppliers for Cholestyramine
Order the CD
ROM |
Primary Information Services 21 Murugappan St, SwamyNagar Ext2, Ullagaram, Chennai - 600091, India.
Phone: 91 44 22421080
Email : informer@eth.net Mobile numbers:9940043898,
9444008898 Fax : 91 44 22423753 |